1. Wallace DJ, Hahn BH, (Eds): Dubois' Lupus Erythematosus. 2007, Philadelphia: Lippincott Williams & Wilkins, 7
2. Decker JL, Steinberg AD, Reinertsen JL, Plotz PH, Balow JE, Klippel JH: NIH conference: systemic lupus erythematosus: evolving concepts. Ann Intern Med. 1979, 91: 587-604.
3. U.S. Food and Drug Administration: Guidance for Industry on Systemic Lupus Erythematosus: Developing Drugs for Treatment. Accessed July 28, 2010. Also available at Federal Register 70(59):15868, March 29, 2005, [ http://www.fda.gov/ohrms/dockets/dockets/05d01-6/05d0106.htm ]
4. U.S. Food and Drug Administration: Guidance for Industry on Systemic Lupus Erythematosus: Developing Medical Products for Treatment. Accessed July 28, 2010, [ http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm ]
5. Yee CS, Farewell V, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Bowman S, Maddison P, Zoma A, Allen E, Gordon C, British Isles Lupus Assessment Group: Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum. 2006, 54: 3300-3305. 10.1002/art.22162.